Cargando…

TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients

BACKGROUND: Acute kidney injury (AKI) is an important complication in surgical patients. Existing biomarkers and clinical prediction models underestimate the risk for developing AKI. We recently reported data from two trials of 728 and 408 critically ill adult patients in whom urinary TIMP2•IGFBP7 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunnerson, Kyle J., Shaw, Andrew D., Chawla, Lakhmir S., Bihorac, Azra, Al-Khafaji, Ali, Kashani, Kianoush, Lissauer, Matthew, Shi, Jing, Walker, Michael G., Kellum, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729326/ https://www.ncbi.nlm.nih.gov/pubmed/26816218 http://dx.doi.org/10.1097/TA.0000000000000912

Ejemplares similares

Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study
por: Liu, Kathleen D., et al.
Publicado: (2016)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations
por: Chindarkar, Nandkishor S., et al.
Publicado: (2015)

Urine TIMP2 × IGFBP7 increases 24 hours before severe AKI
por: Ostermann, M, et al.
Publicado: (2014)

Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury
por: Joannidis, Michael, et al.
Publicado: (2019)

The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck(®) parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment
por: Knafl, Daniela, et al.
Publicado: (2017)

Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel
por: Guzzi, Louis M., et al.
Publicado: (2019)

Urinary Biomarkers TIMP-2 and IGFBP7 Early Predict Acute Kidney Injury after Major Surgery
por: Gocze, Ivan, et al.
Publicado: (2015)

Urinary TIMP-2 and IGFBP7 as Early Biomarkers of Acute Kidney Injury and Renal Recovery following Cardiac Surgery
por: Meersch, Melanie, et al.
Publicado: (2014)

TIMP-2 and IGFBP7 in human kidney biopsies in renal disease
por: Schanz, Moritz, et al.
Publicado: (2023)

Cell-cycle arrest and acute kidney injury: the light and the dark sides
por: Kellum, John A., et al.
Publicado: (2016)

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
por: Kashani, Kianoush, et al.
Publicado: (2013)

Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
por: Hoste, Eric, et al.
Publicado: (2020)

Moving toward a contemporary classification of drug-induced kidney disease
por: Karimzadeh, Iman, et al.
Publicado: (2023)

Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults
por: Ostermann, Marlies, et al.
Publicado: (2018)

Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery
por: Wang, Yimei, et al.
Publicado: (2017)

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
por: Bagshaw, Sean M., et al.
Publicado: (2021)

TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors
por: Adler, Christoph, et al.
Publicado: (2018)

Evaluating TIMP-2 and IGFBP-7 as a predictive tool for kidney injury in ureteropelvic junction obstruction
por: Mello, Marcos Figueiredo, et al.
Publicado: (2021)

Renal angina: concept and development of pretest probability assessment in acute kidney injury
por: Chawla, Lakhmir S, et al.
Publicado: (2015)

Association between urinary TIMP-2 and IGFBP7 as early biomarkers of AKI and oliguria during liver surgery: a prospective pilot study
por: Desmet, F, et al.
Publicado: (2015)

Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection
por: Kellum, John A., et al.
Publicado: (2021)

Routine Adoption of TIMP2 and IGFBP7 Biomarkers in Cardiac Surgery for Early Identification of Acute Kidney Injury
por: Levante, Chiara, et al.
Publicado: (2018)

Urinary [TIMP-2] × [IGFBP-7] for predicting acute kidney injury in patients undergoing orthotopic liver transplantation
por: Schiefer, Judith, et al.
Publicado: (2019)

Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery
por: Pilarczyk, Kevin, et al.
Publicado: (2015)

Urinary TIMP2 and IGFBP7 as early biomarkers of acute kidney injury in septic and nonseptic critically ill patients
por: Cuartero , M, et al.
Publicado: (2015)

The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery
por: Esmeijer, Kevin, et al.
Publicado: (2021)

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers
por: Hoste, Eric A.J., et al.
Publicado: (2014)

Urinary TIMP2⋅IGFBP7 for the prediction of platinum-induced acute renal injury
por: Schanz, Moritz, et al.
Publicado: (2017)

Incidence of Acute Kidney Injury in Polytrauma Patients and Predictive Performance of TIMP2 × IGFBP7 Biomarkers for Early Identification of Acute Kidney Injury
por: Golino, Gianlorenzo, et al.
Publicado: (2022)

Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?
por: Wetz, Anna J, et al.
Publicado: (2015)

Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients
por: Daubin, Delphine, et al.
Publicado: (2017)

The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis
por: Liu, Chao, et al.
Publicado: (2017)

Urinary NGAL, IGFBP-7, and TIMP-2: novel biomarkers to predict contrast medium-induced acute kidney injury in children
por: Sun, Qianliang, et al.
Publicado: (2022)

The predictive value of [TIMP-2]*[IGFBP7] in adverse outcomes for acute kidney injury: a systematic review and meta-analysis
por: Wang, Wenlei, et al.
Publicado: (2023)

Permissive hypofiltration
por: Chawla, Lakhmir S, et al.
Publicado: (2012)

Acute kidney injury biomarkers offer the opportunity to reduce exposure to nephrotoxic drugs
por: Ostermann, M, et al.
Publicado: (2015)

Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
por: Pilarczyk, Kevin, et al.
Publicado: (2022)

Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients
por: Greco, Massimiliano, et al.
Publicado: (2023)

Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients
por: Gunnerson, Kyle J, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_udfkuhbrhgkark0uh8cgu1kop2